Newswise — Springfield, New Jersey, USA (June 2015)- DRG International’s Renin (Active) ELISA for testing of active Renin in human EDTA plasma will be on display at the AACC’s 2015 show Atlanta, Georgia on July 27-30. The DRG® Renin active ELISA test is accurate in testing for certain types of hypertension and has been utilized by labs world-wide.

By measuring the active renin levels in a sample, the DRG® Renin (Active) ELISA (EIA-5125) can also effectively detect hypertension in a pregnancy. This early discovery opens up a much more effective array of treatment methods for the patient.

“The DRG Renin (Active) ELISA Kit allows research laboratories to quickly and easily measure for Renin,” said Dr. Cyril E. Geacintov, founder, president and CEO of DRG International. “The accuracy of our test has made it the top choice of researchers in the field and its applications continue to grow.”

The DRG Renin (Active) ELISA is a solid phase enzyme-linked immunosorbent assay based on the sandwich principle.

DRG International will be showcasing at the AACC in Booth 819. Press inquiries are welcome. For more information, please contact Gregory Guest (International Marketing Manager for DRG International) at (973) 564-7555.


DRG International, Inc. founded in 1970, is a multinational specialty medical equipment and diagnostics manufacturer and distributor with successful operations in over 110 countries.

DRG supplies an extensive line of immunodiagnostic products including fertility and pregnancy tests, endocrinology/diabetes, saliva hormone diagnostics, tumor markers, infectious diseases, immunology/hematology, thyroid function panels, cardiovascular assays as well as therapeutic and toxicology screening products. To obtain more information about the DRG group of companies and complete product line, please visit our New website at: